Prosthetic Control Via Amplified Nerve Signals, EP4486259A1

The European Patent Office published Patent EP4486259A1 on April 15, 2026, granting exclusive rights to The Regents of the University of Michigan for neural-signal-based prosthetic control technology. The patent application covers systems and methods for controlling prosthetic devices using amplified nerve signals, with designated states spanning the full EU membership plus additional European countries. The inventors named are Cynthia Anne Chestek, Paul S. Cederna, Philip Vu, and Alex Vaskov.\n\nFor competitors in the prosthetics and neural-interface device space, this patent establishes IP barriers in European markets for similar amplified nerve signal control systems. Companies developing competing prosthetic control technologies should conduct freedom-to-operate analyses for the European territory before commercializing products in this domain. The University of Michigan may seek licensing arrangements for parties interested in utilizing the patented technology.